Acacia Research (ACTG) Expected to Announce Earnings on Thursday

Key Points

• Acacia Research will report Q1 2026 results on Thursday, May 7 before the market opens (earnings call at 8:00 AM ET), with analysts projecting EPS of ($0.09) and revenue of $50.0 million.
• In the prior quarter (reported Mar. 11) Acacia beat estimates with EPS of $0.03 (vs. a -$0.14 consensus) and revenue of $50.13 million, and the stock carries a consensus price target of $6.00 with mixed buy/hold analyst ratings.
• Institutional ownership is high at about 86.7%, with several funds (including Invesco and Bridgeway Capital) recently increasing their stakes, signaling sizable hedge fund interest.

Acacia Research (NASDAQ:ACTG - Get Free Report) is projected to release its Q1 2026 results before the market opens on Thursday, May 7th. Analysts expect Acacia Research to post earnings of ($0.09) per share and revenue of $50.00 million for the quarter. Interested persons can check the company's upcoming Q1 2026 earning summary page for the latest details on the call scheduled for Thursday, May 7, 2026 at 8:00 AM ET.

Acacia Research (NASDAQ:ACTG - Get Free Report) last issued its earnings results on Wednesday, March 11th. The business services provider reported $0.03 earnings per share for the quarter, beating the consensus estimate of ($0.14) by $0.17. The business had revenue of $50.13 million for the quarter, compared to the consensus estimate of $38.00 million. Acacia Research had a net margin of 7.60% and a return on equity of 4.11%.

Acacia Research Stock Up 0.2%

Shares of NASDAQ:ACTG opened at $4.96 on Thursday. The company has a market cap of $478.49 million, a price-to-earnings ratio of 21.57 and a beta of 0.44. The firm's 50-day simple moving average is $4.72 and its 200-day simple moving average is $4.08. The company has a quick ratio of 8.64, a current ratio of 9.18 and a debt-to-equity ratio of 0.10. Acacia Research has a fifty-two week low of $2.99 and a fifty-two week high of $5.22.

Institutional Inflows and Outflows

A number of hedge funds have recently added to or reduced their stakes in the stock. Invesco Ltd. increased its holdings in Acacia Research by 4.4% in the fourth quarter. Invesco Ltd. now owns 77,143 shares of the business services provider's stock valued at $289,000 after buying an additional 3,252 shares in the last quarter. NewEdge Advisors LLC purchased a new position in Acacia Research in the fourth quarter valued at about $123,000. Empowered Funds LLC increased its holdings in Acacia Research by 11.3% in the fourth quarter. Empowered Funds LLC now owns 244,586 shares of the business services provider's stock valued at $915,000 after buying an additional 24,752 shares in the last quarter. Occudo Quantitative Strategies LP purchased a new position in Acacia Research in the fourth quarter valued at about $49,000. Finally, Bridgeway Capital Management LLC increased its holdings in Acacia Research by 65.4% in the fourth quarter. Bridgeway Capital Management LLC now owns 441,886 shares of the business services provider's stock valued at $1,653,000 after buying an additional 174,752 shares in the last quarter. 86.69% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several brokerages have recently weighed in on ACTG. Weiss Ratings raised shares of Acacia Research from a "sell (d+)" rating to a "hold (c-)" rating in a report on Friday, March 13th. Wall Street Zen downgraded shares of Acacia Research from a "buy" rating to a "hold" rating in a report on Saturday, March 14th. Finally, Craig Hallum lifted their target price on shares of Acacia Research from $5.00 to $6.00 and gave the company a "buy" rating in a report on Thursday, March 12th. One equities research analyst has rated the stock with a Buy rating and one has assigned a Hold rating to the company's stock. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $6.00.

About Acacia Research

Acacia Research Corporation is a publicly traded patent licensing company based in New York City. The firm specializes in acquiring patented technologies through a network of wholly owned subsidiaries and seeking licensing agreements or settlements with companies that utilize those technologies. Since its founding in 1993, Acacia has built a business model centered on identifying innovative inventions and monetizing them through patent enforcement and strategic partnerships.

The company's activities span a broad range of technology sectors, including life sciences, medical devices, software, telecommunications and consumer electronics.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.